[1] Sigel, R., Naishadham, D. and Jemal, A. (2013) Cancer Statistics 2013. CA: A Cancer Journal for Clinicians, 63, 11-30.
https://doi.org/10.3322/caac.21166
[2] Boyle, P. and Levin, B. (2008) World Cancer Report 2008. International Agency for Research on Cancer, Lyon,
[3] NU. CEPAL. Statistics Division (2017) Cuba's Statistical Yearbook for Latinoamerican and the Caribbean.
http://interwp.cepal.org/anuario_estadistico/Anuario_2017/index-en.htm
[4] Sigel, R., Naishadham, D. and Jemal, A. (2014) Cancerstatistics 2014. CA: A Cancer Journal for Clinicians, 64, 9-29.
[5] Eugenio Vinés, V., María José Orellana, G., Catalina Bravo, M. and David Jofré, P. (2017) Manejo del cáncer de cabeza y cuello: ¿Radioterapia a quién, cuándo y por qué? Revista de otorrinolaringología y cirugía de cabeza y cuello, 77, 81-90.
[6] Thariat, J., Hannoun-Levi, J.M., Myint, A.S., et al. (2013) Past, Present and Future of Radiotherapy for the Benefitof Patients. Nature Reviews Clinical Oncology, 10, 52.
https://doi.org/10.1038/nrclinonc.2012.203
[7] Wang, J.S. and Eisbruch, A. (2016) IMRT for Head and Neckcancer: Reducing Xerostomia and Dysphagia. Journal of Radiation Research, 57, 169-175.
https://doi.org/10.1093/jrr/rrw047
[8] Bentzen, S.M. (2005) Radiation Therapy: Intensity Modulated, Image Guided Biologically Optimized and Evidence Based. Radiotherapy and Oncology, 77, 227-230.
https://doi.org/10.1016/j.radonc.2005.11.001
[9] Filippi, A.R., Vanoni, V. and Meduri, B., et al. (2018) Intensity Modulated Radiation Therapy and Second Cancer Risk in Adults. International Journal of Radiation Oncology, Biology, Physics, 100, 17-20.
https://doi.org/10.1016/j.ijrobp.2017.09.039
[10] Chao, K.S., Ozyigit, G., Blanco, A.I., Thorstad, W.L., Deasy, J.O., Haughey, B.H., Spector, G.J. and Sessions, D.G. (2004) Intensity-Modulated Radiation Therapy Ororopharyngeal Carcinoma: Impact of Tumor Volume. International Journal of Radiation Oncology, Biology, Physics, 59, 43-50.
https://doi.org/10.1016/j.ijrobp.2003.08.004
[11] Dawson, L.A., Anzai, Y., Marsh, L., Martel, M.K., Paulino, A., Ship, J.A. and Eisbruch, A. (2000) Patterns of Local-Regional Recurrence Following Parotid-Sparingconformal and Segmental Intensity-Modulated Radiotherapy for Head and Neck Cancer. International Journal of Radiation Oncology, Biology, Physics, 46, 1117-1126.
https://doi.org/10.1016/S0360-3016(99)00550-7
[12] Butler, E.B., Teh, B.S., Grant III, W.H., Uhl, B.M., Kuppersmith, R.B., Chiu, J.K., Donovan, D.T. and Woo, S.Y. (1999) Smart (Simultaneous Modulated Acceleratedradiation Therapy) Boost: A New Accelerated Fractionation Schedulefor the Treatment of Head and Neck Cancer with Intensity Modulated. Radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 45, 21-32.
https://doi.org/10.1016/S0360-3016(99)00101-7
[13] Corvò, R. (2007) Evidence-Based Radiation Oncology in Head and Neck Squamous Cell Carcinoma. Radiotherapy and Oncology, 85, 156-170.
https://doi.org/10.1016/j.radonc.2007.04.002
[14] Di Nicola, L., Gravina, G.L., Marampon, F., Bonfili, P., Buonopane, S., Di Staso, M., et al. (2010) The Impact of Conventional or Hypofractionated Radiotherapy on Voice Quality and Oncological Outcome in Patients with Early. Glotticcancer. Oncology Reports, 24, 1383-1388.
[15] Roy, S., Mallik, C., Ghorai, S., Hazra, A. and Majumdar, A. (2015) Hypofractionated versus Conventional Radiotherapy with or without Chemotherapy in Head and Neck Cancer: A Comparative Study. Clinical Cancer Investigation Journal, 4, 140-146.
https://doi.org/10.4103/2278-0513.152718
[16] Bourhis, J., Overgaard, J., Audry, H., Ang, K.K., Saunders, M., Bernier, J., et al. (2006) Hyperfractionated or Accelerated Radiotherapy in Head and Neck Cancer: A Meta-Analysis. The Lancet, 368, 843-854.
https://doi.org/10.1016/S0140-6736(06)69121-6
[17] Sanghera, P., McConkey, C., Ho, K.F., Glaholm, J. and Hartley, A. (2007) Hypofractionated Accelerated Radiotherapy with Concurrent Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck. International Journal of Radiation Oncology, Biology, Physics, 67, 1342-1351.
https://doi.org/10.1016/j.ijrobp.2006.11.015
[18] Eisbruch, A., Harris, J., Garden, A.S., Chao, C.K., Straube, W., Harari, P.M., et al. (2010) Multi-Institutional Trial of Accelerated Hypofractionated Intensity-Modulated Radiation Therapy for Early-Stage Oropharyngeal Cancer (RTOG 00-22). International Journal of Radiation Oncology, Biology, Physics, 76, 1333-1338.
https://doi.org/10.1016/j.ijrobp.2009.04.011
[19] Lauve, A., Morris, M., Schmidt-Ullrich, R., Wu, Q., Mohan, R., Abayomi, O., et al. (2004) Simultaneous Integrated Boost Intensity-Modulated Radiotherapy for Locally Advanced Head-and-Neck Squamous Cell Carcinomas: II Clinical Results. International Journal of Radiation Oncology, Biology, Physics, 60, 374-387.
https://doi.org/10.1016/j.ijrobp.2004.03.010
[20] Weissberg, J.B., Pillsbury, H., Sasaki, C.T., Son, Y.H. and Fischer, J.J. (1983) High Fractional Dose Irradiation of Advanced Head and Neck Cancer. Implications for Combined Radiotherapy and Surgery. Archives of Otolaryngology, 109, 98-102.
https://doi.org/10.1001/archotol.1983.00800160032008
[21] Das, S., Thomas, S., Pal, S.K., Isiah, R., John, S., et al. (2013) Hypofractionated Palliative Radiotherapy in Locally Advanced Inoperable Head and Neck Cancer: CMC Vellore Experience. Indian Journal of Palliative Care, 19, 93-98.
https://doi.org/10.4103/0973-1075.116709